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RESUMO 
Hemangioma é um tipo de tumor vascular benigno, originado a partir de 
distúrbios na angiogênese e está presente em cerca de 4% a 5% da população. 
Dentre as complicações mais comuns destacam-se: ulcerações e sangramentos, 
nos casos de hemangiomas localizados no trato gastrointestinal, 
comprometimento da via aérea e da visão, complicações viscerais, obstrução do 
canal auditivo e até déficit na alimentação ou na emissão de sons devido a sua 
presença na região da cavidade oral. O hemangioma de cólon e reto é uma causa 
rara de hemorragia digestiva baixa. O objetivo deste estudo é demonstrar um caso 
de doença hemangiomatosa múltipla em uma paciente internada e submetida a 
tratamento no Hospital Geral Público de Palmas (HGPP).     
Palavras-chave: Hemangioma. Ulcerações. Gastrointestinal. 
 
ABSTRACT 
Hemangiomas are a type of benign vascular tumor, originated from angiogenesis 
disorders and prevalent in approximately 4% to 5% of the population. Among the 
most common complications are: ulcerations and bleeding, in cases of those 
located in the gastrointestinal tract; impairment of airways and vision; visceral 
complications; obstruction of the ear canal causing deficit in hearing; or problems 
in eating or in the emission of sounds due to its presence in the oral cavity. Colon 
and rectum hemangiomas are a rare cause of lower digestive hemorrhage. The 
aim of this study is to demonstrate the case of multiple hemangiomatose disease 
in an inpatient undergoing treatment at the Palmas General Public Hospital 
(HGPP). 
Keywords: Hemangiomas. Ulcerations. Gastrointestinal. 
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INTRODUCTION 
 
Hemangioma is a type of benign vascular tumor, 
originated from angiogenesis disorders, that is, it arises from 
pre-existing blood vessels1,2. These tumors represent 6% of 
benign vascular tumors and are most prevalent in females3. 
Hemangiomas of the colon and rectum are rare and scarcely 
described in literature. 
Hemangiomas of the colon and rectum are a rare 
cause of lower gastrointestinal bleeding and, undoubtedly, 
rectal bleeding is the most frequent clinical element of this 
vascular pathology. In approximately half of patients, 
hemangiomas cause ulceration of the mucosa which bleed to 
within the gastrointestinal lumen4. 
Depending on the intensity of the intestinal bleeding, 
the individual may present alterations to physical examination 
such as sweating, dizziness, asthenia, fatigue, pallor and 
laboratory signs of severe anemia and hypovolemic shock5. 
Although low digestive bleeding is the typical clinical 
manifestation of a patient with hemangiomas in the intestinal 
tract and the symptoms begin as early as still in childhood, 
diagnosis is usually made only in adulthood, especially after 
the third decade of life. As this is a condition of dragged 
elucidation and diagnosis, often, the patient is submitted to 
erroneous treatments due to mistakes in the exclusion of 
differential diagnoses such as inflammatory bowel disease and 
hemorrhoids6. 
This case report aims to discuss the case of an 
outpatient at the hematology service of the Hospital Geral 
Público de Palmas (HGPP) after being diagnosed with multiple 
hemangiomatose disease. 
 
CASE REPORT 
  
KRBO, female, student, resident to Nativity-TO, born 
in 28/04/1984. The patient sought medical care in 2000 
presenting multiple hemangiomas throughout the body 
associated with asthenia. The patient was found to have 
severe anemia. In the same year, she underwent upper 
digestive endoscopy (UDE) to investigate if hemangiomas 
were present in the digestive tract, which showed no 
alterations. Later, still in 2000, the patient presented 
hemangiomas in the oral cavity, so a colonoscopy was 
performed and showed multiple hemangiomas and some 
polyps, but without evidence of active bleeding. In 2001 she 
was hospitalized for severe anemia and the following year she 
started using Noripurum (Iron(III)-hydroxide polymaltose 
complex) and      Folifer (ferrous bisglycinate and folic acid). In 
an outpatient consultation in June 2002, she reported having 
an episode of pareasthesia in the left leg and arm lasting 
about six hours, in addition to headache and nausea. A new 
colonoscopy was performed, which showed multiple 
hemangiomas in the transverse, descending, sigmoid and 
rectal colons, and a cranial computed tomography (CT) 
without abnormalities. During 2002, the doses 
of Noripurum and Folifer were reduced until their 
suspension. UDE was performed on 01/08/2004, which 
showed violate nodulation, similar to those of the palate, in 
the gastric body. According to the pathological report (AP), the 
lesion “could not be ruled out as a gastric polyp”. 
In 2004, the patient reported on consultation that she 
had blackened stools and epigastric pain and, while her 
laboratory tests of June, 2004 were Hb:9 and Ht:27, following 
the melena episode in 2004, her exams changed to Hb:7.3 and 
Ht:23.1. For this reason, the patient required blood 
transfusion. One month later, the patient returned referring 
melena of onset one week earlier and asthenia, with Hb:6.0, 
needing to be transfused again. 
After several outpatient consultations with no 
complaints or physical changes, in 2005, the patient returned 
to the outpatient clinic complaining, once again, of darkened 
stools that began about 24 hours earlier. At the time, the 
exams were: Hb: 8.5 and Ht: 27.8. The conduct was expectant, 
and after 15 days, the patient returned with tests of Hb : 5.5 
and Ht: 19.7. 
In 2006, the laboratory tests and her clinic improved, 
without melena and with tests reaching Hb: 12 and Ht: 31.6 in 
March. Then, the patient presented progressive worsening of 
laboratory parameters, with Hb reaching Hb: 6.8 and Ht: 19 in 
August. Her exams continued with low Hb and Ht values until 
there was an improvement in late 2006, reaching Hb: 9.8 and 
Ht: 30 in November. In 2007 her exams were consistently 
below Hb: 8 and Ht: 25. In August, 2008, patient 
presented Hb:4.8 and Ht:18.6, needing once again to be 
transfused. Laboratory parameters improved with yet another 
relapse in November 2008, when values fell to Hb:4,5 and 
Ht:17. 
In early 2010, the patient required a new transfusion 
due to tests showing Hb: 6.8 and Ht: 24.6. In June 2010, a fecal 
occult blood test was done, coming back as positive. It was 
then that omeprazole exchanged for lansoprazole, always 
keeping the Noripurum. In late 2010, the patient underwent a 
colonoscopy, which demonstrated two polyps in the 
transverse colon, with characteristics compatible with that of 
hemangiomas. In 2012, she complained of asthenia and 
presented Hb: 6 and Ht: 19,9, once again needing blood 
transfusion. A few months later, another transfusion was 
required after Hb and Ht parameters worsened. In July 2012, a 
hemicolectomy was scheduled for the removal of 
the bleeding polyps evidenced in colonoscopy in 2010. 
However, the surgery was not performed and the patient 
required a new transfusion in August of that year. A new 
colonoscopy was performed in December 2012, once again 
showing 1.5 cm hemangiomas in the sigmoid colon and 1-2.5 
cm in the transverse colon liver angle. In January 2013, a new 
transfusion was performed after exams presented Hb: 5.5 Ht: 
10.9. The rest of the year was uneventful and without further 
transfusion until November, when she presented Hb: 6.3 and 
Ht: 19.3, and again in December when Hb: 7.3. Colonoscopy 
was performed in 2013 for resection of the polyps, but this 
was not performed due to the lack of specific material. 
The next transfusion performed on the patient was in 
2014, when she presented Hb: 5.4. In August of 2015, a 
head CT scan was performed (without abnormalities) due to 
complaints of headache. In October she underwent a new 
transfusion after complaints of asthenia and tachycardia on 
exertion, and her exams were Hb: 5.2 and Ht: 21.2. Results of 
an UDE in 2016: normal esophagus, several sessile and 
pediculated polyps in the stomach (one removed for biopsy), 
including one in the anterior wall suggestive of recent 
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bleeding, and normal duodenum. In addition, a sample of a 
bleeding pedunculated lesion on the patient’s right thigh was 
sent to biopsy. Anatomopathological results showed the 
following: fundus gland polyp, negative for H. pylori, and 
capillary hemangioma. In September 2016, the patient was 
transfused again after complaints of darkened stools and Hb: 
6.1, and again in November after Hb: 6.2 and Ht: 18.1. On May 
25, 2017, the patient underwent a chest CT, which showed an 
increase in the cardiac area, a sheet of pericardial fluid and a 
subcutaneous device in the right pectoral region with a 
catheter projected over the right atrium, without other 
changes. An echocardiogram was performed in 2017, which 
confirmed pericardial effusion, but without signs of diastolic 
restriction, and an ejection fraction of 74%. Transfusions were 
performed in July, August, October, November and December 
of the same year. Magnetic resonance imaging performed in 
late 2017 was normal. The patient was transfused again in 
February, May, June, July, August, November, and twice in 
December 2018. New UDE was requested in April 2017, 
returning with normal results. In September she started 
coughing with greenish discharge. CTs of the upper abdomen, 
chest, and pelvis were requested. The upper abdominal CT 
returned with no alterations. The thoracic CT had the 
following results: chest with opacities in left upper and lower 
right pulmonary lobes, and small pleural effusion on the right 
side. The pelvic CT had no alterations as well. In October 2018, 
she presented pulmonary thromboembolism, evidenced by 
images of right pulmonary artery filling failure, mosaic 
pulmonary attenuation (suggestive of perfusion alterations) 
and images suggestive of interstitial thickening or linear 
atelectasis. Rivaroxaban was exchanged for Warfarin in late 
2018. In 2019, the patient had two transfusions done: one in 
January and another February. 
She is currently in use of Valeriana officinalis, Ultrafer 
(polymaltose iron), 
Propranolol, Atenolol, Omeprazole, Noripurum (Iron(III)-
hydroxide polymaltose complex) (no report of dosage and 
interval by the patient), Xarelto (rivaroxaban), beginning 
09/10/2018, Warfarin, started 26/12/2018, Aspirin, 
12/03/2019, and finally continuous use of folic acid (could not 
specify dosage). 
DISCUSSION 
 Hemangiomas are present in approximately 4% to 5% 
of the population. The frequency amongst women is 2 to 3 
times more than men, and the complications also tend to 
affect more females7. 
The main risk factors for the complications in 
individuals with hemangioma, are the location of the tumor 
and its size. Among the complications, the most commonly 
found are the formation of ulcerations, bleeding, in cases of 
hemangiomas located in the gastrointestinal tract, airway and 
vision compromise, visceral complications and others, 
depending on the anatomical location, such as auditory canal 
obstruction and deficit in feeding or sound emission due to 
location in the oral cavity region8. 
Large hemangiomas, regardless of their location, 
deserve special attention due to the high risk of culminating in 
high-output heart failure9. 
With regards to methods of diagnostic imaging, 
endoscopic tests such as fiberoptic bronchoscopy, endoscopy 
and colonoscopy can view hemangiomas located on mucosal 
surfaces of the upper airway and gastrointestinal tract and are 
recommended in these cases. Magnetic resonance imaging is 
the most accurate noninvasive exam for the diagnosis of 
hemangiomas, with sensitivity ranging from 50 to 70% and 
specificity from 90 to 95%10. The diagnosis of colorectal 
hemangioma is suspected on colonoscopy, with the presence 
of vascular ectasia. A biopsy is less used in these cases due to 
the greater risk of bleeding, being reserved only for patients 
with atypical lesions11. 
Cervical and rectal hemangiomas are classified into 
two categories: polypoids and non-polypoids. The non-
polypoid form is the most common and has a pervasive 
pattern of involvement. In these cases, the therapy employed 
is the resection of the affected segment. When they are 
located in the sigmoid and rectum, the technique of low 
colorectal or colon-anal anastomosis is employed to preserve 
the anal sphincters. In small polypoid lesions, endoscopic 
resection may be employed12. 
Regardless of the treatment of choice, it is essential 
to emphasize the importance of knowledge of this pathology 
in order to highlight the possible differential diagnoses, 
recognize the main complications and thus establish the most 
appropriate treatment plan and therapeutic approach for each 
case of hemagiomatose disease. 
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